Biotech

Vigil Neuroscience's Alzheimer's Candidate Shows Encouraging Safety Profile, Plans To Start Mid-Stage Study In Q3

RJK Jr.'s Involvement In Merck Lawsuit Faces Scrutiny Ahead Of Senate Hearing

Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst

RJK Jr.'s Involvement In Merck Lawsuit Faces Scrutiny Ahead Of Senate Hearing

Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst

Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall

Johnson & Johnson Q4 Earnings: Cancer Drugs Performance Drives Revenue Beat, Issues Strong FY25 Outlook

Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall

Johnson & Johnson Q4 Earnings: Cancer Drugs Performance Drives Revenue Beat, Issues Strong FY25 Outlook

Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer

FDA Places Clinical Hold On Atara Biotherapeutics' Two Cell Therapy Programs

Biotech Recent News

Neurology-Focused Tiziana Life Confirms Discovery In Multiple Sclerosis Therapy Study

Tiziana Life Sciences recently discovered new immune biomarkers in SPMS patients treated with nasal foralumab.

What's Going On With KULR Technology Shares Wednesday?

KULR Technology and Scripps Research Institute's Baran Lab develop a groundbreaking pyrolytic carbon electrode.

What's Going On With ImmunoPrecise Antibodies Stock Wednesday?

Immunoprecise shares closed higher on Wednesday after the company announced it developed a new class of GLP-1 therapies.

Sanofi Genzyme Facility Draws FDA Criticism Over Alleged Quality Lapses

FDA issues warning letter to Sanofi over its Genzyme facility, citing process deviations, equipment issues, and quality oversight lapses.

Novo Nordisk Inks License Agreement For Sickle Cell Disease Candidate

IMMvention and Novo Nordisk form a partnership to co-develop oral therapies for sickle cell disease, focusing on BACH1 inhibitors with potential for other diseases.

Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases

An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.

Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine

According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of bird flu in the U.S. and one death associated with the virus.

FDA Approves AstraZeneca's Datroway For Pretreated Breast Cancer Patients

AstraZeneca's Datroway gains FDA approval for HR-positive, HER2-negative breast cancer after prior therapies, based on Phase 3 trial data.

Why Is Moderna Stock Trading Higher On Tuesday?

Moderna secures $590 million from HHS for mRNA flu vaccine development.

FDA Approves Johnson & Johnson's Treatment As First Monotherapy For Treatment-Resistant Depression

FDA approves Johnson & Johnson's Spravato nasal spray as a monotherapy for major depressive disorder, showing superior efficacy in clinical trials.

Valneva Vaccine Shows Sustained Immune Response In Adolescents One Year After Single Shot

Valneva chikungunya vaccine shows strong, sustained immune response in adolescents, supporting potential approvals in Brazil and other regions.

EXCLUSIVE: Coya Therapeutics Expands Its Pipeline With Combo Therapy For Inflammatory Diseases

Coya Therapeutics advances COYA 303 for inflammatory diseases, combining COYA 301 and GLP-1 RA for a synergistic anti-inflammatory effect.

Teva Challenges Drug Price Law's Impact On Innovation, Generics

Teva Pharmaceuticals challenges the Inflation Reduction Act, arguing CMS's drug pricing policies harm generics, biosimilars, and innovation, disrupting healthcare balance.